Skip to main content
. 2017 Apr;91(4):383–391. doi: 10.1124/mol.116.107755

Fig. 8.

Fig. 8.

HIV-1 inhibition by compound II in TZM-bl cells. TZM-bl cells presented with compound II at varying concentrations were infected with HIV-1 (JRCSF strain). Virus infection was measured 2 days later by measuring luciferase activity in the cells. The percentage of the luciferase activity was normalized relative to the HIV-1 infected control TZM-bl cells that were not exposed to compound II. The values are mean ± S.D. from three different experiments involving triplicate measurements.